We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+6.68%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$17.7B
AUM Growth
+$1.64B
Cap. Flow
+$829M
Cap. Flow %
4.68%
Top 10 Hldgs %
32.88%
Holding
1,375
New
60
Increased
737
Reduced
285
Closed
62

Top Buys

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$115M
2
ESS icon
Essex Property Trust
ESS
+$110M
3
AAPL icon
Apple
AAPL
+$103M
4
TSLA icon
Tesla
TSLA
+$101M
5
MSFT icon
Microsoft
MSFT
+$97.5M

Top Sells

Rank Stock Value
1
MAA icon
Mid-America Apartment Communities
MAA
+$122M
2
SUI icon
Sun Communities
SUI
+$107M
3
SPG icon
Simon Property Group
SPG
+$104M
4
WPC icon
W.P. Carey
WPC
+$76.5M
5
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
+$70.5M

Sector Composition

Rank Sector Weight
1 Real Estate 45.88%
2 Technology 16.72%
3 Consumer Discretionary 5.58%
4 Communication Services 5.5%
5 Financials 5.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARVN icon
1151
Arvinas
ARVN
$530M
$10K ﹤0.01%
252
+54
+27% +$2.36K
RYTM icon
1152
Rhythm Pharmaceuticals
RYTM
$7.31B
$10K ﹤0.01%
227
– –
VCEL icon
1153
Vericel Corp
VCEL
$2.38B
$10K ﹤0.01%
195
– –
AMPH icon
1154
Amphastar Pharmaceuticals
AMPH
$907M
$9K ﹤0.01%
194
– –
APGE icon
1155
Apogee Therapeutics
APGE
$10.1B
$9K ﹤0.01%
137
-59
-30% -$2.58K
BEAM icon
1156
Beam Therapeutics
BEAM
$2.68B
$9K ﹤0.01%
283
– –
DYN icon
1157
Dyne Therapeutics
DYN
$4.15B
$9K ﹤0.01%
300
+90
+43% +$2.04K
GHC icon
1158
Graham Holdings Company
GHC
$5.31B
$9K ﹤0.01%
12
-1
-8% -$716
IMCR icon
1159
Immunocore
IMCR
$1.7B
$9K ﹤0.01%
138
– –
KROS icon
1160
Keros Therapeutics
KROS
$197M
$9K ﹤0.01%
133
+22
+20% +$1.3K
ALPN
1161
DELISTED
Alpine Immune Sciences Inc
ALPN
$9K ﹤0.01%
238
– –
GH icon
1162
Guardant Health
GH
$19.1B
$8K ﹤0.01%
412
– –
HRMY icon
1163
Harmony Biosciences
HRMY
$2.08B
$8K ﹤0.01%
239
– –
KYMR icon
1164
Kymera Therapeutics
KYMR
$8.66B
$8K ﹤0.01%
210
-11
-5% -$394
MRUS
1165
DELISTED
Merus
MRUS
$8K ﹤0.01%
186
– –
PTCT icon
1166
PTC Therapeutics
PTCT
$6.18B
$8K ﹤0.01%
289
– –
RCKT icon
1167
Rocket Pharmaceuticals
RCKT
$343M
$8K ﹤0.01%
304
– –
SANA icon
1168
Sana Biotechnology
SANA
$882M
$8K ﹤0.01%
767
– –
VERA icon
1169
Vera Therapeutics
VERA
$2.33B
$8K ﹤0.01%
182
– –
DVAX
1170
DELISTED
Dynavax Technologies
DVAX
$7K ﹤0.01%
529
– –
GPCR icon
1171
Structure Therapeutics
GPCR
$3.37B
$7K ﹤0.01%
153
– –
JANX icon
1172
Janux Therapeutics
JANX
$912M
$7K ﹤0.01%
+187
New +$4.07K
MYGN icon
1173
Myriad Genetics
MYGN
$476M
$7K ﹤0.01%
326
– –
SNDX icon
1174
Syndax Pharmaceuticals
SNDX
$1.7B
$7K ﹤0.01%
314
+72
+30% +$1.61K
SUPN icon
1175
Supernus Pharmaceuticals
SUPN
$2.7B
$7K ﹤0.01%
217
– –
45 46
47
48 49

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Daiwa Securities Group's Q1 2024 Portfolio in Review

As of Q1 2024, Daiwa Securities Group held 1,375 positions worth $17.7B, up 10% from $16.1B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Daiwa Securities Group deployed $829M of net new capital in Q1 2024, opening 60 new positions and adding to 737 existing holdings. Its largest new stake was American Healthcare REIT: 241,461 shares worth $3.56M.

By sector, the portfolio is most concentrated in Real Estate at 46% of assets, down from 52% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Mid-America Apartment Communities, an estimated $122M trimmed.

  • Daiwa Securities Group's largest Q1 2024 buy was American Healthcare REIT: 241,461 shares worth $3.56M.
  • Daiwa Securities Group added most to Equinix in Q1 2024, an estimated $115M increase.
  • Daiwa Securities Group's biggest Q1 2024 reduction was Mid-America Apartment Communities, cutting an estimated $122M.
  • Daiwa Securities Group fully exited SPIRIT REALTY CAPITAL, INC. in Q1 2024, selling an estimated $70.5M.
  • Daiwa Securities Group's ten largest holdings make up 33% of its $17.7B portfolio in Q1 2024.
  • Daiwa Securities Group opened 60 new positions and closed 62 in Q1 2024.
  • Daiwa Securities Group's portfolio value rose 10% quarter-over-quarter to $17.7B.

Based on Daiwa Securities Group's 13F filing for Q1 2024, filed 2 May 2024.